These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32807214)

  • 1. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial.
    Randremanana RV; Raberahona M; Randria MJD; Rajerison M; Andrianaivoarimanana V; Legrand A; Rasoanaivo TF; Randriamparany R; Mayouya-Gamana T; Mangahasimbola R; Bourner J; Salam A; Gillesen A; Edwards T; Schoenhals M; Baril L; Horby P; Olliaro P
    Trials; 2020 Aug; 21(1):722. PubMed ID: 32807214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
    Randremanana RV; Raberahona M; de Dieu Randria MJ; Bourner J; Zadonirina G; Razananaivo H; Mayouya-Gamana T; Mangahasimbola R; Pesonel E; Gillesen A; Rajerison M; Andrianaivoarimanana V; Edwards T; Horby P; Olliaro P
    Trials; 2024 Jul; 25(1):457. PubMed ID: 38970065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report.
    Randremanana R; Andrianaivoarimanana V; Nikolay B; Ramasindrazana B; Paireau J; Ten Bosch QA; Rakotondramanga JM; Rahajandraibe S; Rahelinirina S; Rakotomanana F; Rakotoarimanana FM; Randriamampionona LB; Razafimbia V; De Dieu Randria MJ; Raberahona M; Mikaty G; Le Guern AS; Rakotonjanabelo LA; Ndiaye CF; Rasolofo V; Bertherat E; Ratsitorahina M; Cauchemez S; Baril L; Spiegel A; Rajerison M
    Lancet Infect Dis; 2019 May; 19(5):537-545. PubMed ID: 30930106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar.
    Boisier P; Rahalison L; Rasolomaharo M; Ratsitorahina M; Mahafaly M; Razafimahefa M; Duplantier JM; Ratsifasoamanana L; Chanteau S
    Emerg Infect Dis; 2002 Mar; 8(3):311-6. PubMed ID: 11927030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.
    Andrianaivoarimanana V; Bertherat E; Rajaonarison R; Rakotondramaro T; Rogier C; Rajerison M
    BMC Pulm Med; 2018 May; 18(1):92. PubMed ID: 29843675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The plague in Madagascar: epidemiologic data from 1989 to 1995 and the national control program].
    Champetier de Ribes G; Rasoamanana B; Randriambelosoa J; Rakoto LJ; Rabescn D; Chanteau S
    Sante; 1997; 7(1):53-60. PubMed ID: 9172878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term humoral immune response against Yersinia pestis in plague patients, Madagascar.
    Andrianaivoarimanana V; Iharisoa AL; Rahalison L; Ralimanantsoa ML; Ratsitorahina M; Rakotonanahary RJL; Carniel E; Demeure C; Rajerison M
    BMC Infect Dis; 2020 Nov; 20(1):822. PubMed ID: 33172393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment of experimental pneumonic plague in mice.
    Byrne WR; Welkos SL; Pitt ML; Davis KJ; Brueckner RP; Ezzell JW; Nelson GO; Vaccaro JR; Battersby LC; Friedlander AM
    Antimicrob Agents Chemother; 1998 Mar; 42(3):675-81. PubMed ID: 9517950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy.
    Chanteau S; Rabarijaona L; O'Brien T; Rahalison L; Hager J; Boisier P; Burans J; Rasolomaharo M
    Trans R Soc Trop Med Hyg; 1998; 92(5):572-3. PubMed ID: 9861385
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
    Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F
    PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urban epidemic of bubonic plague in Majunga, Madagascar: epidemiological aspects.
    Boisier P; Rasolomaharo M; Ranaivoson G; Rasoamanana B; Rakoto L; Andrianirina Z; Andriamahefazafy B; Chanteau S
    Trop Med Int Health; 1997 May; 2(5):422-7. PubMed ID: 9217697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonic Plague Transmission, Moramanga, Madagascar, 2015.
    Ramasindrazana B; Andrianaivoarimanana V; Rakotondramanga JM; Birdsell DN; Ratsitorahina M; Rajerison M
    Emerg Infect Dis; 2017 Mar; 23(3):521-524. PubMed ID: 28221119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plague Gives Surprises in the Second Decade of the Twenty-First Century.
    Butler T
    Am J Trop Med Hyg; 2023 Nov; 109(5):985-988. PubMed ID: 37748767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Selective BIN Agar for a Better Rate of Yersinia pestis Isolation from Primary Clinical Specimens in Suspected Madagascar Plague Cases.
    Aftalion M; Aloni-Grinstein R; Andrianaivoarimanana V; Lantoniaina Iharisoa A; Shmaya S; Gur D; Laskar O; Rajerison M; Mamroud E
    J Clin Microbiol; 2021 Jul; 59(8):e0056421. PubMed ID: 33980652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak.
    Andrianaivoarimanana V; Wagner DM; Birdsell DN; Nikolay B; Rakotoarimanana F; Randriantseheno LN; Vogler AJ; Sahl JW; Hall CM; Somprasong N; Cauchemez S; Schweizer HP; Razafimandimby H; Rogier C; Rajerison M
    Clin Infect Dis; 2022 Mar; 74(4):695-702. PubMed ID: 34244722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.
    Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ
    Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends of Human Plague, Madagascar, 1998-2016.
    Andrianaivoarimanana V; Piola P; Wagner DM; Rakotomanana F; Maheriniaina V; Andrianalimanana S; Chanteau S; Rahalison L; Ratsitorahina M; Rajerison M
    Emerg Infect Dis; 2019 Feb; 25(2):220-228. PubMed ID: 30666930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.